This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Government Remove Pharmacology Remove Prescription Related Topics
Ethics Healthcare Provider FDA Food and Drug Administration Healthcare Doctors Prospecting Competition Safety Pharma More Related Topics >
article thumbnail

Psychedelic medicines: are they gaining traction in Europe?

European Pharmaceutical Review

APRIL 13, 2023

The Schedule 1 classification means that these substances cannot be administered by doctors and, though they may be used for the purposes of research a government licence is often required. Pharmacological Reviews. These restrictions provide the first obstacles to scientific research and commercial development. References Nichols DE.

Medicine 113
Medicine Food and Drug Administration Doctors Government 113
article thumbnail

Legal challenges put off label use of gender affirming care drugs in jeopardy

Pharmaceutical Technology

MARCH 16, 2023

The laws proposed in several bills range in their potential influence; from restricting the prescription of gender-affirming drugs to criminalising the use of such drugs to allowing states to pursue lawsuits against parents who allow children to access such treatments. But the funding is not there, he adds.

Ethics 144
Ethics Prescription Safety Healthcare 144
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024